{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:25:25Z","timestamp":1790043925084,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.eururo.2008.08.048","type":"journal-article","created":{"date-parts":[[2008,9,3]],"date-time":"2008-09-03T14:39:31Z","timestamp":1220452771000},"page":"705-712","source":"Crossref","is-referenced-by-count":126,"title":["Six-Year Follow-Up of Botulinum Toxin A Intradetrusorial Injections in Patients with Refractory Neurogenic Detrusor Overactivity: Clinical and Urodynamic Results"],"prefix":"10.1016","volume":"55","author":[{"given":"Antonella","family":"Giannantoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"Mearini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Del Zingaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Porena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2008.08.048_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1464-410X.2006.06192.x","article-title":"Botulinum toxin-type A in the treatment of drug-resistant neurogenic detrusor overactivity secondary to traumatic spinal cord injury","volume":"98","author":"Patki","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2008.08.048_bib2","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/01.ju.0000103274.38694.b1","article-title":"Can higher doses of oxybutynin improve efficacy in neurogenic bladder?","volume":"171","author":"Bennet","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2008.08.048_bib3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00005392-200102000-00032","article-title":"Intravesical electromotive administration of oxybutynin in patients with detrusor hyperreflexia unresponsive to standard anticholinergic regimens","volume":"165","author":"Di Stasi","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2008.08.048_bib4","first-page":"401","article-title":"Botulinum-A toxin in the treatment of detrusor hyperreflexia in spinal cord injury: a new alternative to surgical procedure?","volume":"18","author":"St\u00f6hrer","year":"1999","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2008.08.048_bib5","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","article-title":"Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study","volume":"174","author":"Schurch","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2008.08.048_bib6","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1097\/01.ju.0000127725.48479.89","article-title":"Emerging role of botulinum toxin in the management of voiding dysfunction","volume":"171","author":"Smith","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2008.08.048_bib7","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.eururo.2007.04.026","article-title":"Botulinum toxin A improves the quality of life of patients with neurogenic urinary incontinence","volume":"52","author":"Schurch","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2008.08.048_bib8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.eururo.2005.11.006","article-title":"Cost-consequence analysis evaluating the use of botulinum neurotoxin-A in patients with detrusor overactivity based on clinical outcomes observed at a single UK centre","volume":"49","author":"Kalsi","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2008.08.048_bib9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2007.10.013","article-title":"Botulinum toxin A (Botox\u00ae) intradetrusor injections in adults with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review","volume":"53","author":"Karsenty","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2008.08.048_bib10","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.eururo.2007.08.052","article-title":"Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity","volume":"52","author":"Reitz","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2008.08.048_bib11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.eururo.2006.07.022","article-title":"Botulinum toxin injections for neurogenic and idiopathic detrusor overactivity: a critical analysis of results","volume":"50","author":"Patel","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2008.08.048_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/(SICI)1520-6777(1999)18:2<139::AID-NAU9>3.0.CO;2-U","article-title":"The standardization of terminology in neurogenic lower urinary tract dysfunction: with suggestions for diagnostic procedures. International Continence Society Standardization Committee","volume":"18","author":"St\u00f6hrer","year":"1999","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2008.08.048_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0090-4295(99)80384-7","article-title":"Quality of life of persons with urinary incontinence: development of a new measure","volume":"47","author":"Wagner","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2008.08.048_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/sc.1994.13","article-title":"The international standards booklet for neurological and functional classification of spinal cord injury","volume":"32","author":"Ditunno","year":"1994","journal-title":"Paraplegia"},{"key":"10.1016\/j.eururo.2008.08.048_bib15","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","article-title":"Success of repeat detrusor injections of botulinum A toxin in patients with severe neurogenic detrusor overactivity and incontinence","volume":"47","author":"Grosse","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2008.08.048_bib16","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.eururo.2007.09.034","article-title":"Neurogenic detrusor overactivity treated with English botulinum toxin A: 8-year experience of one single centre","volume":"53","author":"Del Popolo","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2008.08.048_bib17","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1464-410X.2007.06977.x","article-title":"Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction","volume":"100","author":"Akbar","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2008.08.048_bib18","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.urology.2005.05.054","article-title":"Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity","volume":"66","author":"Schulte-Baukloh","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2008.08.048_bib19","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2005.12.010","article-title":"Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity","volume":"49","author":"Apostolidis","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2008.08.048_bib20","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.eururo.2006.01.005","article-title":"Botulinum toxin\u2014new mechanisms, new therapeutic directions?","volume":"49","author":"Chapple","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2008.08.048_bib21","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2004.07.011","article-title":"Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type A in overactive neurogenic bladder","volume":"46","author":"Haferkamp","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2008.08.048_bib22","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.eururo.2008.02.037","article-title":"Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity","volume":"53","author":"Apostolidis","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2008.08.048_bib23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.eururo.2007.08.039","article-title":"Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections","volume":"53","author":"Gam\u00e9","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2008.08.048_bib24","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/01.ju.0000143189.19835.f3","article-title":"Inhibitory effect of intravesically applied botulinum toxin A in chronic bladder inflammation","volume":"173","author":"Vemulakonda","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2008.08.048_bib25","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.apmr.2007.02.009","article-title":"The reliability, validity and impact of the use of the Incontinence Quality of Life questionnaire in patients with neurogenic urinary incontinence: validation of the measure and evaluation of the impact of botulinum toxin type A (BoNT\/A) treatment","volume":"88","author":"Schurch","year":"2007","journal-title":"Arch Phys Med Rehabil"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283808010488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283808010488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,25]],"date-time":"2018-12-25T23:59:10Z","timestamp":1545782350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283808010488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0302283808010488"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2008.08.048","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}